William Pridgen, Director at Virios Therapeutics, Inc. (VIRI), bought 942 shares at $6.32 ($6K) on 2021-07-07, disclosed to the SEC on 2021-07-09.
Scheduled purchase ($6k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VIRI | BUY | 2022-05-18 | $59K | — | Filing → |
| VIRI | BUY | 2022-03-30 | $3K | — | Filing → |
| VIRI | BUY | 2022-03-24 | $12K | — | Filing → |